A robust and quantitative method for tracking liposome contents after intravenous administration-Reference-Cited by-同舟云学术

A robust and quantitative method for tracking liposome contents after intravenous administration

Published:2014-02 Issue: Volume:176 Page:86-93
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Kohli Aditya G.,Kieler-Ferguson Heidi M.,Chan Darren,Szoka Francis C.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference34 articles.

1. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma;Zamboni;Cancer Chemother. Pharmacol.,2004

2. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development;Drummond;J. Pharm. Sci.,2008

3. Liposomes containing chelating agents. Cellular penetration and a possible mechanism of metal removal;Rahman;J. Cell Biol.,1975

4. Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy;Thomas;J. Control. Release,2011

5. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes;Harrington;Clin. Cancer Res.,2001

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery;Nature Communications;2024-03-07

2. Tuning Liposome Stability in Biological Environments and Intracellular Drug Release Kinetics;Biomolecules;2022-12-27

3. Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers;Advanced Drug Delivery Reviews;2021-11

4. Biocompatibility of Biomaterials for Nanoencapsulation: Current Approaches;Nanomaterials;2020-08-22

5. The availability of drug by liposomal drug delivery;Investigational New Drugs;2018-12-13